Agenus (AGEN) EBT Growth (3y) (2013 - 2026)
Agenus (AGEN) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 40.43% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.16% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | 26.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.13% |
| Dec 31, 2025 | 69.48% |
| Sep 30, 2025 | 45.15% |
| Jun 30, 2025 | 12.70% |
| Mar 31, 2025 | 10.49% |
| Dec 31, 2024 | 5.25% |
| Sep 30, 2024 | -35.94% |
| Jun 30, 2024 | 21.69% |
| Mar 31, 2024 | -12.41% |
| Dec 31, 2023 | 40.02% |
| Sep 30, 2023 | 2.85% |
| Jun 30, 2023 | -3.76% |
| Mar 31, 2023 | -10.72% |
| Dec 31, 2022 | -43.67% |
| Sep 30, 2022 | -2.85% |
| Jun 30, 2022 | 1.40% |
| Mar 31, 2022 | -51.95% |
| Dec 31, 2021 | -11.60% |
| Sep 30, 2021 | 89.10% |
| Jun 30, 2021 | -91.67% |